XML 195 R179.htm IDEA: XBRL DOCUMENT v3.26.1
BUSINESS COMBINATIONS (Narrative) (Details) - USD ($)
12 Months Ended
Oct. 31, 2024
Sep. 30, 2024
Jan. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disclosure of detailed information about business combination [line items]            
Contingent consideration       $ 413,000 $ 5,384,000  
Description of arrangement for contingent consideration       US$5.0 million payment if, within the next 12 months after acquisition date, (i) the closing price of the Company’s ADSs does not exceed US$7.50 per ADS for at a least 20 consecutive trading days and (ii) the average daily trading volume of the Company’s ADSs does not equal or exceed 20,000 ADSs for 20 consecutive trading days, andAn amount equal to 50% of the proceeds received by the Company (up to a maximum payment of additional consideration of US$15.0 million) on our entering into certain commercial partnering agreements with certain glucose pump manufacturers within 24 months of the acquisition date. At the acquisition date, the fair value assigned to this element of the contingent consideration was US$1.8 million which was disclosed as a contingent liability in Note 23.    
Fair value gain on contingent consideration       $ 1,870,000 $ 0 $ 0
Waveform Technologies Inc. [Member]            
Disclosure of detailed information about business combination [line items]            
Cash consideration     $ 12,500,000      
Non-cash consideration     3,960,000      
Contingent consideration     6,760,000 0    
Fair value of contingent consideration     6,800,000      
Contingent consideration classified as a current liability     5,000,000      
Contingent consideration classified as contingent liability     1,800,000      
Acquisition-related costs     1,500,000      
Deferred tax liabilities     0 1,200,000    
Inventory     0      
Property, plant and equipment     (1,363,000)      
Goodwill     (12,403,000)      
Consideration transferred     23,220,000      
Fair value gain on contingent consideration       1,800,000    
Net loss of acquiree since acquisition date       10,000    
Waveform Technologies Inc. [Member] | Measurement Period Adjustment [Member]            
Disclosure of detailed information about business combination [line items]            
Inventory     (1,300,000)      
Property, plant and equipment     (200,000)      
Goodwill     300,000      
Waveform Technologies Inc. [Member] | Top of range [Member]            
Disclosure of detailed information about business combination [line items]            
Contingent consideration     20,000,000 $ 20,000,000    
Waveform Technologies Inc. [Member] | Technology based intangibles [Member]            
Disclosure of detailed information about business combination [line items]            
Estimated useful lives of intangible assets (In years)       15 years    
Waveform Technologies Inc. [Member] | Class A Ordinary shares [Member]            
Disclosure of detailed information about business combination [line items]            
Non-cash consideration     36,000,000      
Waveform Technologies Inc. [Member] | American depositary share [Member]            
Disclosure of detailed information about business combination [line items]            
Non-cash consideration     $ 1,800,000      
Metabolomics Diagnostics Limited [Member]            
Disclosure of detailed information about business combination [line items]            
Acquisition-related costs   $ 300,000        
Percentage of voting equity interests acquired   100.00%        
Consideration transferred   $ 900,000        
Extinguishment of monies owed   410,000        
Measurement period adjustments       $ 0    
Metabolomics Diagnostics Limited [Member] | American depositary share [Member]            
Disclosure of detailed information about business combination [line items]            
Consideration transferred   270,000        
Epi Capture Limited [Member]            
Disclosure of detailed information about business combination [line items]            
Cash consideration $ 3,000,000          
Contingent consideration 400,000     400,000    
Acquisition-related costs $ 26,000,000          
Acquired business incurred net loss       160,000,000    
Percentage of voting equity interests acquired 100.00%          
Extinguishment of monies owed   $ 400,000        
Additional consideration $ 500,000          
Description of cumulative revenues payable An amount of US$0.5 million will become payable if cumulative revenues from EpiCapture’s operations reach US$1.0 million within a period of three years          
Measurement period adjustments       0    
Epi Capture Limited [Member] | Top of range [Member]            
Disclosure of detailed information about business combination [line items]            
Contingent consideration       $ 500,000    
Epi Capture Limited [Member] | American depositary share [Member]            
Disclosure of detailed information about business combination [line items]            
Contingent consideration $ 1,700,000